NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
2.400
0.00 (0.00%)
Dec 20, 2024, 2:54 PM EST - Market closed
Company Description
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022.
The company was founded in 2011 and is headquartered in Carmel, Indiana.
NeurAxis, Inc.
| Country | United States |
| Founded | 2011 |
| IPO Date | Aug 9, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 19 |
| CEO | Brian Carrico |
Contact Details
Address: 11611 North Meridian Street, Suite 330 Carmel, Indiana 46032 United States | |
| Phone | (812) 689-0791 |
| Website | neuraxis.com |
Stock Details
| Ticker Symbol | NRXS |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $6.00 |
| CIK Code | 0001933567 |
| CUSIP Number | 64134X201 |
| ISIN Number | US64134X2018 |
| Employer ID | 45-5079684 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Brian Carrico | President, Chief Executive Officer and Director |
| Timothy Robert Henrichs | Chief Financial Officer |
| Dr. Adrian Miranda | Senior Vice President of Science and Technology and Chief Medical Officer |
| Dr. Thomas Carrico | Chief Regulatory Officer and Compliance and Privacy Officer |
| Dr. Christopher Robin Brown D.D.S. | Founder, Director of Innovation and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Dec 2, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Dec 2, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 25, 2024 | 8-K | Current Report |
| Nov 21, 2024 | 8-K | Current Report |
| Nov 15, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Oct 18, 2024 | 8-K | Current Report |
| Oct 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |